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Abstract
Background: Natural products display numerous therapeutic properties (e.g., antibacterial activity), providing the
population with countless benefits. Therefore, the search for novel biologically active, naturally occurring compounds is
extremely important. The present paper describes the antibacterial action of the Copaifera langsdorffii oleoresin and ten
compounds isolated from this oleoresin against multiresistant bacteria; it also reports the antiproliferative activity of the
Copaifera langsdorffii oleoresin and (-)-copalic acid.
Methods: MICs and MBCs were used to determine the antibacterial activity. Time-kill curve assays provided the time that
was necessary for the bacteria to die. The Minimum Inhbitory Concentration of Biofilm (CIMB50) of the compounds that
displayed the best results was calculated. Cytotoxicity was measured by using the XTT assay.
Results: The diterpene (-)-copalic acid was the most active antibacterial and afforded promising Minimum Inhibitory
Concentration (MIC) values for most of the tested strains. Determination of the bactericidal kinetics against some bacteria
revealed that the bactericidal effect emerged within six hours of incubation for Streptococcus pneumoniae. Concerning the
antibiofilm action of this diterpene, its MICB50 was twofold larger than its CBM against S. capitis and S. pneumoniae. The XTT
assay helped to evaluate the cytotoxic effect; results are expressed as IC50. The most pronounced antiproliferative effect
arose in tumor cell lines treated with (-)-copalic acid; the lowest IC50 value was found for the human glioblastoma cell line.
Conclusions: The diterpene (-)-copalic acid is a potential lead for the development of new selective antimicrobial agents
to treat infections caused by Gram-positive multiresistant microorganisms, in both the sessile and planktonic mode. This
diterpene is also a good candidate to develop anticancer drugs.
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Background
The discovery of antimicrobials has enabled physicians
to treat diseases that used to have poor prognosis; how-
ever, resistant strains emerged shortly after microbicidal
agents came into clinical use. The indiscriminate use of
antibiotics has culminated in multiresistant bacterial
strains [1–3], a situation that has prompted researchers
to search for new bactericides in sources like medicinal
plants [4, 5].
In nature, microorganisms generally fix onto surfaces; a
matrix consisting of extracellular polymeric substances syn-
thesized by the microbes themselves incorporates the mi-
croorganisms, creating a sessile population designated
biofilm [6]. Microorganisms associated on a surface exhibit
high growth rates and marked antimicrobial resistance [7].
Researchers have long attempted to develop new biologic-
ally active compounds against many multiresistant bacterial
strains [8]; in this context, medicinal plants have arisen as a
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promising strategy—their antibacterial activity is easy to test
via reliable and reproducible in vitro assays [2].
Cancer currently constitutes one of the leading causes
of death worldwide; chemotherapy and/or radiotherapy
are the main strategies available to treat this disease. The
treatment is usually difficult, due to drug resistance, tox-
icity and low specificity [9]. Since ancient times, plants,
particularly their secondary metabolites, have played an
important part in cancer treatment and have led to the
discovery of several effective anticancer agents that act
directly or indirectly on the tumor [10].
The “Copaiba” oleoresin is extremely interesting from a
chemical viewpoint: it contains a wide variety of secondary
metabolites, mainly diterpenes and sesquiterpenes [11].
Although literature papers have reported that diterpenes
and sesquiterpenes of the genus Copaifera display many
biological activities, few publications on the antibacterial
action of the species Copaifera langsdorffii exist [12–14].
The present work aimed to evaluate the antibacterial and
cytotoxic activities of the C. langsdorffii oleoresin and its
isolated compounds, to contribute to (1) the development
of drugs that can prevent the bacterial growth through
blockage of underlying mechanisms for multiresistant in-
fections and (2) the prevention of cancer progression.
Methods
Plant material and compounds isolation
The authentic oleoresin from Copaifera langsdorffii was
kindly provided by the Brazilian company Apis-Flora
Comercial and Industrial. About 20.0 g of the oleoresin
was fractionated by several chromatographic techniques, as
described by Souza et al. [14]. These procedures furnished
the compounds OC-1 (caryophylene oxide, 117.0 mg);
OC-2 ((-) copalic acid, 450.0 mg); OC-3 (kaurenoic acid);
OC-4 ((-)-acetoxycopalic acid, 230.0 mg); OC-5 ((-)-agathic
acid, 150.0 mg); and OC-6 ((-)-hydroxycopalic acid,
130.0 mg). About 100.0 mg of the compounds OC-2, OC-
4, OC-5 and OC-6 was treated with ethereal diazomethane.
After addition of a small amount of acetic acid (to destroy
the remaining diazomethane) and solvent removal, the
derivatives OC-7, OC-8, OC-9 and OC-10 were obtained
as described by Souza et al. [14]. The 1H and 13C-NMR
spectral data indicated that the purity of each isolated com-
pound ranged from 95 to 98 %.
Antibacterial assay
Bacterial strains
To evaluate the antibacterial activity of the tested com-
pounds, multiresistant clinical isolates and bacterial
strains from the American Type Culture Collection
(ATCC), namely Staphylococcus epidermidis (isolated
from blood), Staphylococcus capitis (isolate from blood),
Staphylococcus haemolyticus (isolate from blood), Entero-
coccus faecalis (isolated from urine), Staphylococcus aureus
(isolated from surgical wound), Staphylococcus aureus
(isolated from catheter), Streptococcus pneumoniae (iso-
lated from blood), Pseudomonas aeruginosa (isolated from
urine), Acinetobacter calcoaceticus (isolated from urine),
Escherichia coli (isolated from urine), Klebsiella pneumo-
niae (isolated from urine), Staphylococcus aureus (WB81-
USA 400), Staphylococcus aureus (W7749-USA 200),
Enterococcus faecium (isolate from hospital outbreak),
Enterococcus faecium (ATCC 19434), Staphylococcus aur-
eus (ATCC 29213), Staphylococcus capitis (ATCC 27840),
Staphylococcus epidermidis (ATCC 14990), Staphylococcus
haemolyticus (ATCC 29970) and Enterococcus faecalis
(ATCC 19433), were employed. The multiresistant clinical
isolates were kindly supplied by Hospital das Clínicas de
Ribeirão Preto (state of São Paulo, Brazil). The antibacterial
activity of the isolated compounds was also tested against
potentially pathogenic bacterial strains—Kocuria rhizophila
(ATCC 9341), Streptococcus pyogenes (ATCC 19615),
Streptococcus pneumoniae (ATCC 6305), Enterococcus
hirae (ATCC 10541), Staphylococcus aureus (ATCC 9144),
Staphylococcus aureus (ATCC 6538), Bacillus subtillis
(ATCC 6051), Bacillus cereus (ATCC 14579), Streptococcus
dysgalactiae (ATCC 9926), Streptococcus agalactiae (ATCC
27591), Staphylococcus epidermidis (ATCC 12228), Entero-
bacter aerogenes (ATCC 13048), Pseudomonas aeruginosa
(ATCC 27853), Escherichia coli (ATCC 14948), Proteus
mirabilis (ATCC 29906), Morganella morganii (ATCC
25829), Citrobacter freundii (ATCC 8090) and Shigella
flexneri (ATCC 12022).
Determination of the Minimum Inhibitory Concentration
and Minimum Bactericidal Concentration
The Minimum Inhibitory Concentration (MIC) values
were determined by the microdilution broth method in 96-
well microplates, in triplicate [15]. The samples were
dissolved in dimethylsulfoxide (DMSO, Sigma-Aldrich) at
1.0 mg mL−1, followed by dilution in Triptic Soy broth
(Difco, Kansas City, MO, USA); concentrations ranging
from 0.2 to 200.0 µg mL−1 were achieved. The final DMSO
content was 5 % (v/v). The inoculum was adjusted for each
organism, to yield a cell concentration of 5 × 105 colony
forming units (CFU) per mL, according to guidelines of
the Clinical and Laboratory Standards Institute (CLSI).
DMSO 5 % (v/v) was used as negative control; vancomycin
and gentamicin were employed as positive control. One in-
oculated well was included, to control broth adequacy for
bacterium growth. Another well containing broth free of
antimicrobial agent and inoculum was included, to control
medium sterility. The microplates (96 wells) were incu-
bated at 37 °C for 24 h. After the incubation period, 30 μL
of resazurin aqueous solution (0.02 %) was added to the
microplates [16] for immediate observation of bacterial
growth: the blue and red color indicated absence and
presence of bacterial growth, respectively. The microplates
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were re-incubated for 30 min; then, they were analyzed in
a descriptive way. To determine MBC, an aliquot of the
inoculum was removed from each well before addition of
resazurin and plated onto tryptic soy agar. Microorganism
growth was detected after the incubation period and com-
pared with the readings obtained in the microplates
(MIC). This provided the concentration that was bacteri-
cidal—Minimum Bactericidal Concentration (MBC), de-
fined as the lowest concentration of the compound that
did not generate visible microbial growth in the medium.
MCB was determined for the most active compound eval-
uated in this report.
Time-kill curves
Time-kill assays were performed in triplicate, based on
D’arrigo et al. [17]. The average values were plotted in
the graphs. The selected times for this evaluation were:
0, 30 min, 2, 4, 6, 12 and 24 h. Compound OC-2 was
chosen for the time-kill curve assays because it was the
most active. The concentration used during the test
was based on the MBC value. The following microor-
ganisms were evaluated: S. aureus (isolated from surgical
wound), S. capitis (isolated from blood), S. epidermidis
(isolated from blood), S. haemolyticus (isolated from
blood), E. faecalis (isolated from urine), and S. pneumoniae
(isolated from blood), because they displayed MBC lower
than 100 µg mL−1.
Antibiofilm activity evaluation
The Minimum Inhibitory Concentration of Biofilm
(MICB50) was determined on the basis of the minor con-
centration of the antibacterial agent that was able to
inhibit 50 % or more of the biofilm. A microtiter plate
assay based on CLSI [15] was used, with some modifica-
tions. Compound OC-2 was selected for antibiofilm ac-
tivity evaluation; it was tested at concentrations ranging
between 0.98 and 2000 µg mL−1. The bacterial strains
were added at a concentration of 1 × 106 CFU mL−1.
Vancomycin was tested as negative control; bacterial
strains in the absence of antibacterial agent were used as
positive control. After a certain time of bacterial growth,
biofilm production was quantified as described previously
by Stepanović et al. [18], on the basis of the colorimetric
measurement of crystal violet incorporated by sessile cells.
The antibiofilm activity was also quantified by using the
number of microorganisms (CFU mL−1).
Cytotoxicity assay
Cell and culture conditions
Different cell lines were employed in this study: normal
cell line, Chinese hamster lung fibroblasts (V79), and the
Table 1 Antibacterial potential of some compounds against potentially pathogenic Gram-positive and Gram-negative bacteria
Microorganisms
(ATCC)
Minimum Inhibitory Concentration - µg mL−1
Compounds
Oleoresin OC-1 OC-2 OC-3 OC-4 OC-5 OC-6 OC-7 OC-8 OC-9 OC-10 PC
K. rhizophila (9341) a a 5.0 10.0 80.0 a a a a a a 0.1
S. pyogenes (19615) a a 3.0 5.0 60.0 a a a a a a 0.1
S. pneumonie (6305) a a 2.0 5.0 50.0 a a a a a a 0.2
E. hirae (10541) a a 15.0 100.0 a a a a a a a 0.4
S. aureus (9144) a a 12.0 20.0 180.0 a a aa a a a 0.4
S. aureus (6538) a a 15.0 18.0 a a a a a a a 0.5
B. subtillis (6051) a a 5.0 12.0 90.0 a a a a a a 0.1
B. cereus (14579) a a 8.0 12.0 100.0 a a a a a a 0.1
S. dysgalactiae (9926) a a 1.0 8.0 80.0 a a a a a a 0.4
S. agalactiae (27591) a a 2.0 10.0 90.0 a a a a a a 0.7
S. epidermidis (12228) a a 0.5 8.0 30.0 a a a a a a 0.5
E. aerogenes (13048) a a a a a a a a a a a 0.7
P. aeruginosa (27853) a a a a a a a a a a a 5.9
E. coli (14958) a a a a a a a a a a a 5.9
P. mirabilis (29906) a a a a a a a a a a a 5.9
M. morganii (25829) a a a a a a a a a a a 5.9
C. freundii (8090) a a a a a a a a a a a 5.9
S. flexineri (12022) a a a a a a a a a a a 1.5
aInactive in the evaluated concentration (MIC values higher than 200 µg mL−1); Positive Control (PC), vancomycin and gentamicin; Negative Control (5 % DMSO solution v/
v) did not affect growth of the microorganisms
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tumor cell lines murine melanoma (B16F10), human
breast adenocarcinoma (MCF-7), human cervical adeno-
carcinoma (HeLa), human hepatocellular liver carcin-
oma (HepG2), and human glioblastoma (MO59J, U343
and U251). The cell lines were maintained as mono-
layers in plastic culture flasks (25 cm2) in culture medium
(HAM-F10 +DMEM, 1:1 or only DMEM, Sigma-Aldrich)
supplemented with 10 % fetal bovine serum (Nutricell), an-
tibiotics (0.01 mg mL−1 streptomycin and 0.005 mg mL−1
penicillin; Sigma-Aldrich), and 2.38 mg mL−1 Hepes
(Sigma-Aldrich), at 37 °C, with 5 % CO2 or in a BOD-type
chamber.
Antiproliferative activity
Cytotoxicity was measured by using the in vitro Toxicol-
ogy Colorimetric Assay Kit (XTT; Roche Diagnostics)
according to the manufacturer’s instructions. For these
experiments, 1 × 104 cells were plated onto 96-well micro-
plates. Each well received 100 μL of HAM-F10/DMEM or
DMEM medium containing C. langsdorffii oleoresin at
concentrations ranging from 15 to 7630 µg mL−1 and OC-
2 at concentrations ranging from 1.21 to 9830 μg mL−1.
The negative (without treatment), solvent (Tween 80
0.25 %), and positive controls—doxorubicin (DXR,
Zodiac), (S)-(-)-camptothecin (CPT, Sigma-Aldrich) and
etoposide (VP16, Sigma-Aldrich)—were included. After
incubation at 37 °C for 24 h, the medium was removed.
The cells were washed twice with 100 μL of phosphate
buffered saline (PBS) and exposed to 100 μL of HAM-F10
medium without phenol red. Then, 50 μL of XTT were
added to each well. The microplates were covered and in-
cubated at 37 °C, for 17 h. The absorbance of the samples
was determined by using a multiplate reader (ELISA,
Tecan – SW Magellan vs 5.03 STD 2PC) at a test wave-
length of 492 nm and a reference wavelength of 690 nm
[19]. The experiments were accomplished in triplicate.
The antiproliferative activity was assessed with the aid of
the parameter of 50 % inhibition of cell line growth (IC50)
and selectivity index (SI, normal cells IC50/tumor cells
IC50). The experiments were conducted in triplicate.
Results and Discussion
In the present study, we have determined the Minimum
Inhibitory Concentration (MIC) of (1) the C. lansgsdorffii
oleoresin, (2) one sesquiterpene and five diterpenes isolated
from fractions of the C. langsdorffii oleoresin, and (3) four
semisynthetic compounds. Table 1 lists the MIC values for
potentially pathogenic bacteria; Table 2 summarizes the
Table 2 Antibacterial activity of ent-copalic acid against multiresistant Gram-positive and Gram-negative bacteria
Minimum Inhibitory Concentration - µg mL−1
Multiresistant Microorganisms Copalic acid (OC-2) Positive Control
S. epidermidis (ATCC 14490) 50.0 1.5
S. epidermidis (clinical isolate) 15.6 1.5
S. capitis (ATCC 27840) 50.0 0.7
S. capitis (clinical isolate) 31.25 0.7
S. aureus (WB81-USA 400) 25.0 0.7
S. aureus (W7749-USA 200) 25.0 0.7
S. aureus (ATCC 29213) 25.0 0.7
S. aureus (surgical wound) 15.6 1.5
S. aureus (catheter) a 1.5
E. faecalis (ATCC 19433) 25.0 1.5
E. faecalis (clinical isolate) 15.6 5.9
E. faecium (ATCC 19434) 50.0 1.5
E. faecium (hospital outbreak) 50.0 5.9
S. haemolyticus (ATCC 29970) 100.0 1.5
S. haemolyticus (clinical isolate) 15.6 1.5
S. pneumoniae (clinical isolate) 31.25 2.9
P. aeruginosa (clinical isolate) a 5.9
A. calcoaceticus (clinical isolate) a 0.4
E. coli (clinical isolate) a 5.9
K. pneumoniae (clinical isolate) a 2.9
aInactive in the evaluated concentration (MIC values higher than 200 µg mL-1); Positive Control (PC), vancomycin and gentamicin; Negative Control (5 % DMSO solution v/
v) did not affect growth of the microorganisms
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MIC values for multiresistant bacteria. Figure 1 illustrates
the chemical structures of the secondary compounds ob-
tained from C. langsdorffii and evaluated in this work; Fig. 2
depicts the semisynthetic compounds obtained from the
diterpenes of C. langsdorffii.
MIC values against Gram-positive and Gram-negative
potentially pathogenic microorganisms ranged from 0.5 to
over 200.00 μg mL−1 for the evaluated compounds. After
preliminary evaluation of the MIC values (Table 1), we de-
termined the antibacterial activity of the most promising
compound—the diterpene OC-2—against Gram-positive
and Gram-negative multiresistant bacteria.
According to Table 2, compound OC-2 was the most
promising agent against multiresistant bacteria, with MIC
values ranging from 15.60 to 31.25 μg mL−1 for a large
number of tested microorganisms. Because exposure of
Staphylococcus aureus (isolated from surgical wound),
Staphylococcus epidermidis (clinical isolate), Staphylo-
coccus haemolyticus (clinical isolate), Staphylococcus
capitis (clinical isolate), Enterococcus faecalis (clinical
isolate) and Streptococcus pneumoniae (clinical isolate)
to OC-2 yielded promising results, we selected these
strains to continue evaluating the antibacterial activity
of this compound by the Minimum Bactericidal Con-
centration (MBC) assay (Table 3). The MBC results
confirmed that OC-2, the main biomarker of the genus
Copaifera [20], was active against the multiresistant
strains S. aureus (surgical wound), S. haemolyticus, S.
capitis E. faecalis and S. pneumoniae.
The Gram-positive bacteria were more sensitive to the
tested compounds than the Gram-negative bacteria, prob-
ably because these two groups of bacteria have different
Fig. 1 Chemical structures of the evaluated compounds
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cell walls in which the compounds act at distinct locations.
Indeed, besides the plasmatic membrane, Gram-positive
bacteria bear a thick wall that consists predominantly of
peptidoglycan; Gram-negative bacteria possess a stratified
wall constituted of an external membrane, a fine stratum
and an inner peptidoglycan-based plasmatic membrane.
Bearing these features in mind, we suspect that antimicro-
bials have more difficulty penetrating Gram-negative
bacteria: their external stratum composed of lipopolysac-
charide determines surface properties like permeability and
susceptibility to antibiotics. In other words, the external
membrane of Gram-negative bacteria most likely acts as a
barrier to active substances.
The chemical structures of the evaluated compounds
revealed that modifications to the molecular structure
markedly altered the antibacterial activity: the methyl-
ated diterpenes (OC-7 to OC-10) did not display any
action; the diterpenes from which the aforementioned
diterpenes originate (OC-2, OC-4, OC-5 and OC-6) did.
Studies conducted by our research group [14, 15]
Fig. 2 Chemical structures of the methylated compounds
Table 3 Minimum Bactericidal Concentration of ent-copalic acid against multiresistant Gram-positive bacteria
Multiresistant microorganisms Minimum bactericidal concentration µg mL−1
Copalic acid OC-2 Positive control
S. aureus (cirurgical wound) 15.6 1.5
S. epidermidis (clinical isolate) 31.25 1.5
S. haemolyticus (clinical isolate) 15.6 1.5
S. capitis (clinical isolate) 31.25 0.7
E. faecalis (clinical isolate) 15.6 5.9
S. pneumoniae (clinical isolate) 31.25 2.9
Positive Control (PC), vancomycin
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confirmed this and highlighted which structural charac-
teristics in diterpenes elicit promising antibacterial activ-
ity. For example, existence of one hydrogen-bond donor
group (HBD; hydrophilic group) interacting with phos-
phorylated groups on the membrane of the bacterial cell
seemed to be crucial. The presence of a second HBD
reduced or abated the antibacterial activity of the com-
pound. The present study confirmed this theory—we
obtained results similar to those that Souza et al. [14]
achieved when they used the same compounds against
cariogenic bacteria. The Gram-negative bacteria were
more resistant to OC-2, affording MIC values higher
than 200 μg mL−1. One Gram-positive strain (S. aureus,
isolated from catheter) was resistant to this diterpene,
possibly because it was a more robust strain than the
other strains assessed in this study.
We constructed time-kill curves for the selected multi-
resistant bacteria (Fig. 3) to verify how long it was neces-
sary for OC-2 to completely kill the microorganisms.
According to Fig. 3, OC-2 eliminated all the tested
bacteria within 24 h of incubation. Inhibition of bacterial
growth started to decrease after 12 h of incubation; the
bactericidal potential of OC-2 became evident between
18 and 24 h.
Medoza et al. [21] stated that the time-kill curve
depended on the bacterial species and on the concen-
tration of the tested compound. The results obtained in
this work agreed with the data presented by Souza et al.
[13] and Souza et al. [14] when they tested copalic acid
against cariogenic and anaerobic bacteria. We found
that S. pneumoniae exhibited a distinct behavior: OC-2
eliminated this bacterium within only 6 h of incubation,
which was a satisfactory result that confirmed the anti-
bacterial activity of this compound (Fig. 1).
As for the Minimum Inhibitory Concentration of Bio-
film (MICB50) calculated for OC-2, it ranges from 62.5
to 2000 μg mL−1; this compound displayed 50 % anti-
biofilm activity against all the tested bacteria (Fig. 4),
Fig. 3 Bactericidal kinetics of copalic acid against multiresistant bacteria
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especially Streptococcus pneumoniae, Staphylococcus aur-
eus and Staphylococcus capitis. More specifically, treatment
of Enterococcus faecalis, Staphylococcus epidermidis,
Streptococcus pneumoniae, Staphylococcus haemolyti-
cus, Staphylococcus capitis and Staphylococcus aureus
with OC-2 furnished MICB50 values of 1000.0, 2000.0,
62.5, 250.0, 62.5 and 62.5 μg mL−1, respectively (Fig. 4).
To investigate the antibiofilm potential of the diterpene
OC-2, we determined the MICB50—the smallest concen-
tration of antibacterial agent that is able to inhibit the for-
mation of biofilm mode by 50 % or more—by optical
density and the number of microorganisms (CFU mL−1)
(Fig. 4). Quantification consisted in using crystal violet as
the coloring agent. We removed crystal violet with an
appropriate solvent after a certain incubation period and
measured the absorbance [18, 22]. However, this technique
did not measure cell viability. Therefore, we also removed
the non-adhered cells; re-suspended, homogenized and
diluted the biofilm; and diluted aliquots in Brain and
Heart Infusion (BHI) agar to determine the number of
CFU mL−1. One issue was that second method could
generate biofilm agglomerates, which would be difficult
to dissociate in suspensions used for cell counting in
agar. Despite their individual limitations, the combin-
ation of these two techniques was satisfactory: it
afforded reliable results on antibiofilm activity. Litera-
ture reports have pointed out that biofilms can be 10–
1000 times more resistant to antibacterial effects than a
Fig 4 Antibiofilm activity of Copalic acid as demonstrated by optical density (A570) and number of microorganisms (Log10 CFU mL
−1)
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planktonic culture of the same strain [23,24]. Compar-
ing the MIC and MICB50 values obtained for OC-2, this
compound provided fourfold, twofold and twofold
higher MICB50 for Staphylococcus aureus, Staphylococ-
cus capitis and Streptococcus pneumonia, respectively,
as compared with MIC. Ceri et al. [25] and Gursoy et
al. [26] have also reported lower MIC values as com-
pared with MICB50. On the basis of the present results
and of the data published in Souza et al. [14], medicinal
plants derivatives may pave the way for the develop-
ment of new semisynthetic molecules. In this sense,
OC-2 constitutes a potential agent to act against Gram-
positive multiresistant bacteria that can form a biofilm.
Table 4 shows the IC50 values and the selectivity index
obtained for the normal and the tested tumor cell lines
after treatment with the C. langsdorffii oleoresin and
OC-2. The C. langsdorffii oleoresin and OC-2 yielded
IC50 values of 365.90 and 107.30 μg mL
−1 for the normal
cell line V79, respectively. The C. langsdorffii oleoresin
was only active against the tumor cell line MCF7 (IC50
= 488.90 μg mL−1). The IC50 values achieved for the
tumor cell lines treated with OC-2 ranged from 44.03 to
351.20 μg mL−1.
The diterpene OC-2 exerted a more pronounced
antiproliferative effect on the HeLa tumor cell line,
IC50 = 44.03 μg mL
−1, which was significantly lower
than the value obtained for the normal cell line V79
(IC50 = 107.30 μg mL
−1) and upon treatment of HeLa
cells with the well-known chemotherapeutic drug
VP16 (IC50 = 225.50 μg mL
−1). Treatment with OC-2
afforded the highest selectivity index for the HeLa cell
line.
Conclusion
Among the compounds tested in this study, the diter-
pene OC-2 was the most active antibacterial, especially
against Gram-positive multiresistant bacteria, and it
exerted the most pronounced antiproliferative effect
against cancer cell lines. Therefore, this diterpene repre-
sents a potential drug to treat infections caused by multi-
resistant bacteria both in the planktonic and sessile mode;
it is also a promising lead to develop anticancer drugs.
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